Back to TSHA
LANARK FINANCIAL, INC. TSHA Position History
Taysha Gene Therapies, Inc. • Healthcare
Quarters held
4
Latest value
$266K
Q3 2026
Peak value
$375K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $291K |
| Q1 2026 | $242K |
| Q2 2026 | $375K |
| Q3 2026 | $266K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $266K | 54.6K | — | — |
| Q2 2026 | $375K | 55.0K | — | — |
| Q1 2026 | $242K | 54.1K | — | — |
| Q4 2025 | $291K | 53.0K | — | — |